Next Article in Journal
Repurposing FDA-Approved Agents to Develop a Prototype Helicobacter pylori Shikimate Kinase (HPSK) Inhibitor: A Computational Approach Using Virtual Screening, MM-GBSA Calculations, MD Simulations, and DFT Analysis
Next Article in Special Issue
Hypidone Hydrochloride (YL-0919), a Sigma-1 Receptor Agonist, Improves Attention by Increasing BDNF in mPFC
Previous Article in Journal
Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(2), 172; https://doi.org/10.3390/ph18020172
Action Date Notes Link
article xml file uploaded 27 January 2025 10:55 CET Original file -
article xml uploaded. 27 January 2025 10:55 CET Update https://www.mdpi.com/1424-8247/18/2/172/xml
article pdf uploaded. 27 January 2025 10:55 CET Version of Record https://www.mdpi.com/1424-8247/18/2/172/pdf
article html file updated 27 January 2025 10:57 CET Original file https://www.mdpi.com/1424-8247/18/2/172/html
Back to TopTop